Literature DB >> 18573841

Autoimmune diseases in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.

N M Nielsen1, M Frisch, K Rostgaard, J Wohlfahrt, H Hjalgrim, N Koch-Henriksen, M Melbye, T Westergaard.   

Abstract

BACKGROUND: Multiple sclerosis (MS) and other autoimmune diseases might cluster. Our aim was to estimate the relative risk (RR) of other autoimmune diseases among MS patients and their first-degree relatives in a population-based cohort study.
METHODS: Using the Danish Multiple Sclerosis Register, the Danish Hospital Discharge Register, and the Danish Civil Registration System, we estimated RRs for 42 different autoimmune diseases in a population-based cohort of 12 403 MS patients and 20 798 of their first-degree relatives. Ratios of observed to expected numbers of autoimmune diseases, based on national sex-, age-, and period-specific incidence rates, served as measures of the RRs.
RESULTS: Compared with the general population, MS patients were at an increased risk of developing ulcerative colitis (RR = 2.0 (95% confidence interval (CI): 1.4-2.8), n = 29) and pemphigoid (RR = 15.4 (CI: 8.7-27.1), n = 12) but at reduced risk of rheumatoid arthritis (RR = 0.5 (CI: 0.4-0.8), n = 28) and temporal arteritis (RR = 0.5 (CI: 0.3-0.97), n = 11). First-degree relatives of MS patients were at increased risks of Crohn's disease (RR = 1.4 (CI: 1.04-1.9), n = 44), ulcerative colitis (RR = 1.3 (CI: 0.99-1.7), n = 51), Addison's disease (RR = 3.4 (CI: 1.3-9.0), n = 4), and polyarteritis nodosa (RR = 3.7 (CI: 1.4-10.0), n = 4). PATIENTS: with MS and their first-degree relatives seem to be at an increased risk of acquiring certain other autoimmune diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18573841     DOI: 10.1177/1352458508088936

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  29 in total

1.  Relationship between target antigens and major histocompatibility complex (MHC) class II genes in producing two pathogenic antibodies simultaneously.

Authors:  L R Zakka; D B Keskin; P Reche; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 2.  [Neuroimmunology and rheumatology: overlap and differential diagnoses].

Authors:  C Trebst; T Kümpfel
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

3.  Association of Demyelinating and Inflammatory Bowel Diseases: A Case Series and Overview of the Literature.

Authors:  Murat Mert Atmaca; Güneş Altiokka Uzun; Erkingül Shugaiv; Murat Kürtüncü; Mefküre Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

Review 4.  Genetics of Multiple Sclerosis: An Overview and New Directions.

Authors:  Nikolaos A Patsopoulos
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

Review 5.  Inflammatory bowel disease: an increased risk factor for neurologic complications.

Authors:  Germán Morís
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 6.  Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.

Authors:  Ruth Dobson; Gavin Giovannoni
Journal:  J Neurol       Date:  2013-01-12       Impact factor: 4.849

7.  Psoriasis during interferon beta treatment for multiple sclerosis.

Authors:  Loredana La Mantia; F Capsoni
Journal:  Neurol Sci       Date:  2009-11-19       Impact factor: 3.307

8.  Association Between Pemphigus and Neurologic Diseases.

Authors:  Khalaf Kridin; Shira Zelber-Sagi; Doron Comaneshter; Arnon D Cohen
Journal:  JAMA Dermatol       Date:  2018-03-01       Impact factor: 10.282

9.  Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions.

Authors:  Kari Hemminki; Xinjun Li; Jan Sundquist; Jan Hillert; Kristina Sundquist
Journal:  Neurogenetics       Date:  2008-10-09       Impact factor: 2.660

Review 10.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.